Ligand Pharmaceuticals Incorporated
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2024
Total Assets: $941.8M
Liabilities Breakdown FY2024
Total Liabilities: $111.3M
Asset Breakdown
Total Assets: $941.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $72.3M | 7.7% |
| Accounts Receivable | $38.4M | 4.1% |
| Inventory | $14.1M | 1.5% |
| Property, Plant & Equipment | $15.1M | 1.6% |
| Goodwill | $105.3M | 11.2% |
| Intangible Assets | $266.6M | 28.3% |
| Other Assets | $429.9M | 45.7% |
Liabilities Breakdown
Total Liabilities: $111.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.2M | 4.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $106.1M | 95.3% |